key: cord-0274717-p79djztg
authors: Wu, Xudong; Rapoport, Tom A.
title: Cryo-EM structure determination of small proteins by nanobody-binding scaffolds (Legobodies)
date: 2021-08-10
journal: bioRxiv
DOI: 10.1101/2021.08.09.455715
sha: 7267deaa8a3d66bb8fca16c70e27e4b35f512783
doc_id: 274717
cord_uid: p79djztg

We describe a general method that allows structure determination of small proteins by single-particle cryo-electron microscopy (cryo-EM). The method is based on the availability of a target-binding nanobody, which is then rigidly attached to two scaffolds: (1) a Fab-fragment of an antibody directed against the nanobody, and (2) a nanobody-binding protein A fragment fused to maltose binding protein and Fab-binding domains. The overall ensemble of ∼120 kDa, called Legobody, does not perturb the nanobody-target interaction and facilitates particle alignment in cryo-EM image processing. The utility of the method is demonstrated for the KDEL receptor, a 23 kDa membrane protein, resulting in a map at 3.2Å overall resolution with density sufficient for de novo model building, and for the 22 kDa RBD of SARS-CoV2 spike protein, resulting in a map at 3.6 Å resolution that allows analysis of the binding interface to the nanobody. The Legobody approach thus overcomes the current size limitations of cryo-EM analysis.

Single-particle electron cryo-microscopy (cryo-EM) has become the method of 47 choice for the determination of protein structures. Cryo-EM analysis has several 48 advantages over X-ray crystallography or NMR 1 , but the method becomes 49 increasingly challenging for smaller proteins. Large molecules are relatively easy 50 to identify in noisy low-dose images of vitrified samples and have sufficient 51 contrast and features to determine their orientation and position for alignment 52 and averaging. The structural analysis of small particles (~100 kDa or less) is 53 much more difficult. Without symmetry, they require optimal conditions, such as a 54 highly homogeneous sample, rigid protein conformation, and random particle 55 distribution in thin ice, conditions that are difficult to achieve with most samples 2 . 56

However, structure determination of small proteins is of great interest, as most 57

proteins have sizes below 100 kDa and ~50% are smaller than 50 kDa, including 58 many membrane proteins and proteins of medical importance. It is thus a major 59 goal in the field to expand the use of cryo-EM to the routine analysis of small 60 proteins. 61 62 One approach to employ cryo-EM for small proteins is based on phase contrast 63 methods, such as the use of Volta phase plates. This method has been used to 64 determine the structure of streptavidin, a protein of 52 kDa, at 3.2 Å resolution 3 . 65

However, the structure of this protein could be determined even without phase 66 plates 4 , likely because streptavidin forms rigid tetramers and the particles 67 display a near-perfect distribution in very thin ice, which greatly facilitates 68 structural analysis. 69 70 An alternative strategy is to make the target protein larger, either by fusing it to 71 another protein or by using a binding partner. In either case, high rigidity of the 72 added scaffold itself and its rigid connection to the target protein are required to 73 facilitate particle alignment and averaging in cryo-EM images. 74 75 overcome if one could increase their size with the rigid attachment of a large 107 scaffold. One reported attempt is to fuse a large protein into a loop of the 108 nanobody, generating a "megabody" 13 . However, the fusion did not result in a 109 rigid connection of the scaffold to the protein of interest and it therefore did not 110 sufficiently facilitate particle alignment, as indicated by the fact that the method 111 has only been applied to the cryo-EM analysis of particles larger than 100 kDa. 112 113

Here, we describe a versatile method that allows cryo-EM analysis of even the 114 smallest protein once a tightly binding nanobody is available. The size of the 115 nanobody is increased to ~120 kDa by two rigidly attached scaffolds. The overall 116 design is reminiscent of a Lego construction, so we propose to call the 117 scaffolds/nanobody ensemble "Legobody". The utility of the Legobody method is 118 demonstrated by structures of two small proteins (22 kDa and 23 kDa) that are 119 asymmetric monomers and have a size well below the estimated limit for direct 120 cryo-EM single-particle analysis (~40 kDa) 14 . The Legobody approach can easily 121 be applied to any target protein and should greatly expand the use of cryo-EM 122 single-particle analysis by overcoming the current size limitations. 123 124

Our first nanobody-interacting scaffold is a Fab fragment of an antibody that is 127 directed against a surface present in many nanobodies and not involved in target 128 interaction. To generate such a Fab, we raised monoclonal antibodies in mice 129 against a nanobody (Nb_0) that contains a framework sequence almost identical 130 to that used in two libraries employed for rapid in vitro screening 11,12 . Amino 131 acids in the antigen-interacting complementarity-determining regions (CDRs) of 132

Nb_0 were chosen to minimize the immunogenicity of the antigen-interacting 133 surface (see Table S1 for sequence). To select for monoclonals that do not 134 perturb nanobody-antigen interaction, hybridoma clones were screened with a 135 complex of a nanobody against MBP (Nb_MBP) and its antigen MBP 11 . After 136 several rounds of selection, hybridoma clone 8D3 was obtained, which produced 137 monoclonal antibodies that strongly bind to both Nb_0 and the Nb_MBP/MBP 138 complex. The yield is about 5~8 mg from 1L of cell culture. Recombinantly purified 151

Fab_8D3 forms a stable complex with nanobody Nb_0, as shown by co-migration 152 of the proteins in size-exclusion chromatography (Fig. 1a) . 153

To identify the exact interaction surface, we determined a crystal structure of the 155 complex of Fab_8D3 and Nb_0. After confirming that the crystals contained both 156 components (Fig. S1a) , a structure of the complex was determined at 1.8 Å 157 resolution ( Fig. 1b; Table. S2) . As expected, Fab_8D3 binds to a surface of 158

Nb_0 that is distal from the CDRs and contains conserved amino acids present in 159 many nanobodies ( Fig. 1c; Fig. S1b ). The Fab-interacting amino acids of Nb_0 160 are located in loops between β-strands A and B, C and C', E and F, as well as in 161 segments of the β-strands A and G (Fig. 1c) . Amino acids introduced by the 162 cloning of the His-tag are also involved. The extensive interactions between the 163 Fab and nanobody generate a rigid interface, a conclusion supported by the B-164 factor profile of the X-Ray structure (Fig. S1c) . 165

166

The second scaffold was developed on the basis of reports that protein A from 168

Staphylococcus aureus can bind to nanobodies 15 . Protein A contains five repeats 169 of three-helical bundles (domains A, B, C, D and E). All these domains associate 170

with the constant region of IgG antibodies, but also bind with different affinities to 171 the variable region of the heavy chain of some antibodies (human V H 3 family) 16 , 172 a region that is similar in sequence to the common framework of many 173 nanobodies. Consistent with this sequence homology, protein A has been 174 reported to interact with nanobodies in a similar way as with Fabs 17 . To identify 175 the strongest binding protein A domain, we fused domain D (PrAD) and the most 176 divergent domains C and E (PrAC and PrAE) through a long, flexible linker to 177 MBP (MBP_L_PrAC, MBP_L_PrAD and MBP_L_PrAE) and tested these fusions 178 for their interaction with a nanobody. Co-elution of the proteins in size-exclusion 179 chromatography showed that all three domains interact with the nanobody, but 180 domain C forms the most stable complex (Fig. S2a) . 181 182 Next, we grafted domain C of protein A (PrAC; ~6 kDa) to MBP to generate a 183 larger nanobody-binding partner. MBP is frequently used as an N-terminal fusion 184 partner, as it can increase the solubility of its fusion partners. Although fusions 185

can be designed as helical extensions of the C-terminal helix of MBP and have 186 been extensively used in X-ray crystallography 18 , such linkers are not rigid 187 enough for cryo-EM analysis. To generate a more rigid connection between 188

PrAC and MBP, we used the "shared helix" approach 19 , applying it to a helix of 189 domain C that is not involved in nanobody interaction (Fig. S2b) . Residues on 190 one side of this helix were mutated to those of MBP's C-terminal helix that face 191 the core of MBP. The resulting construct MBP_PrAC (Fig. 1d) (Fig. 1e) . 195 196

The nanobody surfaces interacting with Fab_8D3 and MBP_PrAC are not 198 overlapping (Fig. 2a, b) , providing an opportunity to use both scaffolds at the 199 same time. To increase the stability of the ensemble, we fused to the C-terminus 200 of MBP_PrAC two Fab-binding domains. One is the domain D of protein A 201 (PrAD), which has been shown to interact with the variable region of the heavy 202 chain of Fabs 20 . The other is protein G (PrG), which is known to strongly interact 203 with the constant region of the heavy chain 21 . All domains were connected by 204 short linkers, generating a scaffold designated MBP_PrA/G (Fig. 2a, b) . The complex between Fab_8D3_2 and MBP_PrA/G was assembled before 212 adding a nanobody. All three components co-migrated in size-exclusion 213 chromatography (Fig. 2c) . Negative-stain EM showed strong structural features 214

for the different parts of the Legobody (Fig. 2d) , suggesting overall rigidity of the 215 assembly, an assumption confirmed by subsequent cryo-EM analysis (see 216 below). The assembly of the complex from individual pieces is reminiscent of a 217

Lego construction, so we propose to call it a "Legobody". 218 219

To test the utility of the Legobody method, we first chose a small membrane 221 protein, the KDEL receptor. This protein binds to the C-terminal KDEL sequence 222 of luminal endoplasmic reticulum (ER) proteins that have escaped the ER, so 223 that these proteins can be returned from the Golgi to the ER by vesicular 224 transport 22 . The KDEL receptor has seven trans-membrane segments and a 225 molecular weight of only ~23kDa. A crystal structure of the KDEL receptor in 226 complex with a tightly binding nanobody has been reported 23 . 227

To generate a sample suitable for cryo-EM analysis, we devised a protocol that 229

should be applicable to many other challenging membrane proteins (Fig. 3a) . 230

The solubilized KDEL receptor (KDELR), tagged with a streptavidin-binding 231 peptide, was first immobilized on streptavidin beads. We employed the detergent 232 DMNG, as it resulted in a more homogeneous sample than DDM used for the 233 crystal structure 23 . The beads containing KDELR were then incubated with 234

Legobody containing the reported nanobody against KDELR 23 . Finally, to reduce 235 aggregation during purification, the complex was reconstituted into nanodisc on 236 the beads. After elution from the beads with biotin, the complex of KDELR, 237

Legobody, and nanodisc was further purified by size-exclusion chromatography 238 ( Fig. 3b) . Negative-stain EM showed features for the Legobody and nanodisc 239 ( Fig. 3c) . 240

We next analyzed the complex by cryo-EM. When placed directly onto EM grids, 242 the particles showed severe aggregation and strong preferred orientation, likely 243 caused by denaturation of the molecules at the water-air interface. To alleviate 244 this problem, surface lysine residues were modified with low molecular weight 245 polyethylene glycol (PEG), a previously introduced method that makes the 246 surface of proteins more hydrophilic and reduces their denaturation on the grids 247 24 . Although the particles still showed some aggregation and preferred orientation 248 ( Fig. S3) , the cryo-EM analysis was straightforward, as the size and unique 249 shape of the Legobody greatly facilitated particle picking and 2D and 3D Legobody and KDELR had well-resolved structural features, allowing even the 256 visualization of the maltose molecule bound to MBP ( Fig. 4a; Fig. S4a ). The 257 local resolution ranged from 3.0 to ~4.0 Å and showed that the interactions 258 between the two scaffolds and the nanobody, as well as the connection between 259

PrAC and MBP, are all rigid (Fig. 4b) . Because the nanobody is tightly 260 associated with the KDELR, and because the center of alignment of the 261 Legobody is at the position of the nanobody, an excellent map was obtained for 262 the KDELR (Fig. 4c) . The local resolution of this part of the map ranged from 3.0 263 to ~3.5 Å and all amino acid side chains of the KDELR were clearly visible. In 264 addition, several bound phospholipid molecules could easily be identified. The 265 cryo-EM structure of the KDEL/nanobody complex is almost identical to that 266 obtained by X-ray crystallography (Fig. S4b) 23 . The RBD was expressed in HEK293 cells as a secreted protein and purified by 277

Ni-NTA chromatography on the basis of an attached His-tag. The protein was 278 mixed with the pre-assembled Legobody containing a reported nanobody against 279 the RBD 27 . The complex was further purified by size-exclusion chromatography 280 ( Fig. 5a) and analyzed by cryo-EM. After 2D and 3D classification, followed by 281 3D refinement, a map with an overall resolution of 3.6 Å was obtained, again with 282 little directional differences in resolution ( Fig. 5b; Fig. S5a (Fig. 5c) . Specifically, the 285 RBD region showed good side-chain density for amino acids at the interface with 286 the nanobody (Fig. 5d) . The cryo-EM structure of the RBD/nanobody complex is 287 almost identical to that obtained by X-ray crystallography (Fig. S5f) 28 . Some 288 polypeptide loops distal to the binding interface were invisible in the cryo-EM 289 map (Fig. S5f) . The biased particle orientation suggests that this may be caused 290 by the partial denaturation of the RBD at the water/air interface, i.e. by issues 291 unrelated to the Legobody method. The moderate preferred particle orientation 292 observed with the KDELR and the somewhat stronger bias seen with the RBD 293 are likely not caused by the Legobody itself, as the populated angles were 294 different. 295 296

The Legobody method was developed using nanobodies that have a common 298 framework similar to that used in two in vitro libraries 11,12 . However, the method 299

can be applied to nanobodies that originally have a different framework, such as 300 those often generated in alpaca. For example, a nanobody directed against the 301 ALFAtag peptide, which is frequently used to purify or visualize fusion proteins 29 , 302 differs significantly in its framework sequence (sequence identity ~75%) and 303 would therefore not allow interactions with our scaffolds. Specifically, nine amino 304 acid residues in the Fab-and PrAC-interacting regions were different from the 305 ones in the common framework and thus mutated, resulting in Nb_ALFA that 306 could be assembled into a Legobody (Figs. S6a; S6b). These mutations did not 307 affect antigen binding, as GST-tagged ALFA peptide was able to pull-down the 308 pre-assembled Legobody containing the modified nanobody (Fig. S6b) . We 309 therefore believe that all nanobodies can be used, regardless of whether they are 310 obtained from in vitro libraries or from animal species. 311 312

Here we describe a general method that allows cryo-EM structures to be 314 determined for small proteins. Our Legobody approach thus overcomes current 315 limitations of cryo-EM analysis and greatly expands its use. The new method can 316 be applied to any target protein once a tightly binding nanobody is available. The 317 nanobody is assembled into a Legobody by the binding of two scaffolds, a Fab 318 fragment and a MBP molecule to which domain C of protein A domain has been 319 grafted (MBP_PrAC). All interactions were designed to be rigid. In addition, Fab-320 interacting domains were fused to MBP_PrAC to further solidify the complex. The 321

Legobody has a characteristic shape, consisting of two lateral arms, formed by 322 the two scaffolds, and a central lobe, contributed by the nanobody. The overall 323 size (~120 kDa) and shape of the Legobody, and the center of alignment at the 324 position of the nanobody, greatly facilitate all steps of cryo-EM analysis, from 325 particle picking, classifications, to final refinement. We demonstrate the utility of 326 the Legobody method with two examples of small target proteins (KDELR 327 (23kDa) and the RBD (22kDa) of the SARS-CoV-2 spike protein). 328

The membrane protein KDELR poses a particular challenge for cryo-EM 330 analysis, as it is small, has no domains outside membrane, and no symmetry to 331 facilitate particle alignment in EM images. The protein tends to aggregate during 332 purification and on cryo-EM grids at the water-air interface of thin ice. To 333 determine its structure, we not only used the Legobody approach, but also 334 employed two other tricks, which likely are applicable to other challenging 335 membrane proteins. First, we used a purification strategy, in which the 336 KDELR/Legobody complex was incorporated into nanodisc while bound to beads 337 (Fig. 3a) . This strategy reduces aggregation of the receptor and increases its 338 stability in solution. Second, before applying the sample to EM grids, we modified 339 surface lysines with low-molecular weight PEG. We have used this protocol 340 routinely for other proteins 24,30,31 , and it often dramatically reduces particle 341 aggregation and preferred particle orientation. Using standard cryo-EM data 342 analysis, we were able to obtain a high-quality map for the KDELR, with density 343 visible for all amino acid side chains. The map would have allowed straight-344 forward de novo model building. Table. S1). Fab_8D3_2 was purified in the same way as the original Fab_8D3. 465

Purified His-tagged Fab_8D3 was mixed with purified His-tagged Nb_0 nanobody 468 at a molar ratio of 1:3. The mixture was treated with carboxypeptidase A (Sigma) 469 overnight at 4 °C to remove the His-tags. The sample was subjected to size-470 exclusion chromatography on a S200 increase 10/300 GL column in 25mM 471 HEPES pH 7.4, 150mM NaCl. The peak fractions of the complex were pooled 472 and concentrated to 10mg/ml and used to set up crystal screens. 

The sequences of all MBP fusion proteins are given in Table. NaCl, 20mM imidazole. The proteins were purified by Ni-NTA chromatography 495 using lysis buffer as washing buffer. After elution with imidazole, proteins were 496 subjected to size-exclusion chromatography on a S200 increase 10/300 GL 497 column in 25mM HEPES pH 7.4, 150mM NaCl, 5% glycerol. The peak fractions 498 were stored for future use. 499 500 Purification of GST fused ALFA peptide 501 GST fused ALFA peptide was purified as follows. The gene for the ALFA peptide 502 was cloned into the pGEX6p1 vector (Cytiva). The expression was induced by 503 addition of 1mM IPTG for 5hrs at 30 °C. The cells were lysed by sonication in 504 25mM HEPES pH 7.4, 400mM NaCl. The proteins were purified by GST resins 505 using lysis buffer as washing buffer. After elution with reduced glutathione (GSH), 506

proteins were subjected to size-exclusion chromatography on a S200 increase 507 10/300 GL column in 25mM HEPES pH 7.4, 150mM NaCl, 5% glycerol. The 508 peak fractions were stored for future use. 509 510

Legobodies were assembled by first incubating purified MBP_PrA/G with 512

Fab_8D3_2 at a molar ratio of 1: 1.1 in 25mM HEPES pH 7.4, 150mM NaCl. 513

Then, the mixture was incubated with a chosen nanobody added at a 3-fold 514 molar excess over MBP_PrA/G. The sample was applied to an amylose resin 515 and the complex was eluted with 25mM HEPES pH 7.4, 150mM NaCl, 20mM 516 maltose. The Legobodies were further purified by size-exclusion chromatography 517 on a S200 increase 10/300 GL column in 25mM HEPES pH 7.4, 150mM NaCl, 518 5% glycerol, 2mM maltose. The peak fractions of the complexes were 519 concentrated and stored for future use. 520 521

The codon-optimized gene for the full-length KDELR with a SBP tag at its C- 

Legobody 548

The codon-optimized gene for the RBD domain (residues 334-526) of SARS-549

CoV-2 spike protein with an N-terminal Flag tag and a C-terminal His8 tag was 550 cloned into the pCAGEN vector. The RBD was expressed and purified in the 551 same way as the Fabs. After elution from Ni-NTA beads, the protein was 552 subjected to size-exclusion chromatography on a S75 increase 10/300 GL 553 column in 25mM HEPES pH 7.4, 150mM NaCl. Peak fractions were mixed with 554

Legobody at a molar ratio of 3:1. The mixture was subjected to size-exclusion 555 chromatography on a S200 increase 5/150 GL column in 25mM HEPES pH 7.4, 556

150mM NaCl, 2mM maltose. The peak fractions of the complex were 557 concentrated, snap-frozen, and stored for cryo-EM analysis. 558

The KDELR/Legobody complex at 0.8mg/ml was PEGylated by incubation with 561 MS(PEG)12 methyl-PEG-NHS-ester (Thermo Fisher) at a 1:40 molar ratio for 2 562 hrs on ice to reduce preferred particle orientation on the grids. The chosen ratio 563 allows a maximum of 1/3 of the total lysines to be modified, which minimizes 564 effects of PEG modification on the stability of the complex. The PEGylated 565 sample was then applied to a glow-discharged quantifoil gold grid (1. Nb_0/Fab_8D3 (Fig. 1b) shown as red sticks deviate from those seen in the common nanobody framework (in yellow) and would interfere with the assembly into a Legobody.

They were therefore mutated to generate Nb_ALFA. b, To demonstrate that Nb_ALFA can be assembled into the Legobody without loss of antigen binding, purified Legobody containing Nb_ALFA was incubated with or without a GST fusion of ALFA peptide (GST_ALFA peptide). The samples were incubated with glutathione beads and the bound material analyzed by SDS-PAGE and Coomassie-blue staining. The input corresponds to 50% of the material used for the pull-down. Table S4 .

Crystal structures of target/nanobody complexes were aligned with the structure of the Legobody on the basis of the nanobody.

Steric clashes with the different Legobody domains are listed. The Table shows only one entry for a target protein if several similar structures have been reported. In some cases, the existences of clashes are uncertain (labeled as "possible").

Clash with MBP_PrAC

How cryo-EM is 645 revolutionizing structural biology

High-resolution structure 648 determination of sub-100 kDa complexes using conventional cryo-EM. 649

Single particle cryo-EM reconstruction of 52 kDa streptavidin 651 at 3.2 Angstrom resolution

High-yield monolayer graphene grids for near-atomic 653 resolution cryoelectron microscopy

Structure of human Frizzled5 by fiducial-assisted cryo-656 EM supports a heterodimeric mechanism of canonical Wnt signaling

A 3.8 Å resolution cryo-EM structure 659 of a small protein bound to an imaging scaffold

Fusion of DARPin to 662

Aldolase Enables Visualization of Small Protein by Cryo-EM

Cryo-EM structure of the human L-type amino acid 665 transporter 1 in complex with glycoprotein CD98hc

Structure and mechanism of the ER-based 668 glucosyltransferase ALG6

Structure and drug resistance of the Plasmodium falciparum 670 transporter PfCRT

Synthetic single domain antibodies for the 672 conformational trapping of membrane proteins

Yeast surface display platform for rapid discovery of 674 conformationally selective nanobodies

Megabodies expand the nanobody toolkit for protein 677 structure determination by single-particle cryo-EM

The potential and limitations of neutrons, electrons and X-680 rays for atomic resolution microscopy of unstained biological molecules

Isolation of antigen specific llama VHH antibody 683 fragments and their high level secretion by Saccharomyces cerevisiae

All individual domains of 686 staphylococcal protein A show Fab binding

Engineered 689 high-affinity nanobodies recognizing staphylococcal Protein A and suitable 690 for native isolation of protein complexes

Protein science : a 693 publication of the

Construction of novel repeat proteins with rigid and 695 predictable structures using a shared helix method

Crystal structure of a Staphylococcus aureus protein A 698 domain complexed with the Fab fragment of a human IgM antibody: 699 structural basis for recognition of B-cell receptors and superantigen activity

The third IgG-binding domain from 703 streptococcal protein G. An analysis by X-ray crystallography of the 704 structure alone and in a complex with Fab

ERD2, a yeast 707 gene required for the receptor-mediated retrieval of luminal ER proteins 708 from the secretory pathway

Structural basis for pH-dependent retrieval of ER proteins 710 from the Golgi by the KDEL receptor

Structural basis of ER-associated protein degradation 712 mediated by the Hrd1 ubiquitin ligase complex

SARS-CoV-2 Cell Entry Depends on ACE2 and 714 TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Slaying SARS-CoV-2 One 717 (Single-domain) Antibody at a Time

Synthetic nanobodies targeting the SARS-CoV-2 719 receptor-binding domain

722 Synthetic nanobody-SARS-CoV-2 receptor-binding domain structures 723 identify distinct epitopes

The ALFA-tag is a highly versatile tool for nanobody-726 based bioscience applications

Structure of the post-translational 729 protein translocation machinery of the ER membrane

LDAF1 and Seipin Form a Lipid Droplet Assembly 732 Complex

Complex between Peptostreptococcus magnus protein L 734 and a human antibody reveals structural convergence in the interaction 735 modes of Fab binding proteins

A structurally distinct human mycoplasma protein that 737 generically blocks antigen-antibody union

Electroporation and RNA interference in the 739 rodent retina in vivo and in vitro

Regulatable promoters of 742 Saccharomyces cerevisiae: comparison of transcriptional activity and their 743 use for heterologous expression

MotionCor2: anisotropic correction of beam-induced 746 motion for improved cryo-electron microscopy

CTFFIND4: Fast and accurate defocus 749 estimation from electron micrographs

SPHIRE-crYOLO is a fast and accurate fully automated 752 particle picker for cryo-EM

New tools for automated high-resolution cryo-EM 754 structure determination in RELION-3

Addressing preferred specimen orientation in single-756 particle cryo-EM through tilting

Macromolecular structure determination using X-rays, 758 neutrons and electrons: recent developments in Phenix

of the Legobody components are labeled and shown in different shades of yellow 874 and orange. The density for MBP-bound maltose is shown in red. c, Two views of 875 the final map colored according to local resolution

Map and fitted model for the interface between the RBD and nanobody

We thank S. Sterling